David A Katz1, Colleen A McHorney. 1. Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. dak@medicine.wisc.edu
Abstract
OBJECTIVES: To determine the association between insomnia and health-related quality of life (HRQOL) in patients with chronic illness after accounting for the effects of depression, anxiety, and medical comorbidities. STUDY DESIGN: We used a cross-sectional analysis of Medical Outcomes Study (MOS) data. POPULATION: The sample consisted of 3445 patients who completed a self-administered questionnaire and who were given a diagnosis of 1 or more of 5 chronic medical and psychiatric conditions by an MOS clinician. Patients were recruited from the offices of clinicians practicing family medicine, internal medicine, endocrinology, cardiology, and psychiatry in 3 US cities. OUTCOMES MEASURED: Outcomes were sleep items, health-related quality of life as measured by the Medical Outcomes Study Short Form Health Survey (SF-36), chronic medical comorbidity, depression, and anxiety. Insomnia was defined as the complaint of difficulty initiating or maintaining sleep. RESULTS: Insomnia was severe in 16% and mild in 34% of study patients. Patients with insomnia demonstrated significant global decrements in HRQOL. Differences between patients with mild insomnia versus no insomnia showed small to medium decrements across SF-36 subscales ranging from 4.1 to 9.3 points (on a scale of 0 to 100); the corresponding decrements for severe insomnia (versus no insomnia) ranged from 12.0 to 23.9 points. CONCLUSIONS: Insomnia is independently associated with worsened HRQOL to almost the same extent as chronic conditions such as congestive heart failure and clinical depression.
OBJECTIVES: To determine the association between insomnia and health-related quality of life (HRQOL) in patients with chronic illness after accounting for the effects of depression, anxiety, and medical comorbidities. STUDY DESIGN: We used a cross-sectional analysis of Medical Outcomes Study (MOS) data. POPULATION: The sample consisted of 3445 patients who completed a self-administered questionnaire and who were given a diagnosis of 1 or more of 5 chronic medical and psychiatric conditions by an MOS clinician. Patients were recruited from the offices of clinicians practicing family medicine, internal medicine, endocrinology, cardiology, and psychiatry in 3 US cities. OUTCOMES MEASURED: Outcomes were sleep items, health-related quality of life as measured by the Medical Outcomes Study Short Form Health Survey (SF-36), chronic medical comorbidity, depression, and anxiety. Insomnia was defined as the complaint of difficulty initiating or maintaining sleep. RESULTS:Insomnia was severe in 16% and mild in 34% of study patients. Patients with insomnia demonstrated significant global decrements in HRQOL. Differences between patients with mild insomnia versus no insomnia showed small to medium decrements across SF-36 subscales ranging from 4.1 to 9.3 points (on a scale of 0 to 100); the corresponding decrements for severe insomnia (versus no insomnia) ranged from 12.0 to 23.9 points. CONCLUSIONS:Insomnia is independently associated with worsened HRQOL to almost the same extent as chronic conditions such as congestive heart failure and clinical depression.
Authors: Molly E Zimmerman; Marcelo E Bigal; Mindy J Katz; Adam M Brickman; Richard B Lipton Journal: J Int Neuropsychol Soc Date: 2012-02-09 Impact factor: 2.892
Authors: Nalaka S Gooneratne; Grace E Dean; Ann E Rogers; J Emeka Nkwuo; James C Coyne; Larry R Kaiser Journal: Lung Cancer Date: 2007-08-31 Impact factor: 5.705
Authors: Molly E Zimmerman; Marcelo E Bigal; Mindy J Katz; Carol A Derby; Richard B Lipton Journal: J Clin Sleep Med Date: 2013-04-15 Impact factor: 4.062
Authors: J Todd Arnedt; Leisha Cuddihy; Leslie M Swanson; Scott Pickett; James Aikens; Ronald D Chervin Journal: Sleep Date: 2013-03-01 Impact factor: 5.849
Authors: Lauren Hale; Terrence D Hill; Elliot Friedman; F Javier Nieto; Loren W Galvao; Corinne D Engelman; Kristen M C Malecki; Paul E Peppard Journal: Soc Sci Med Date: 2012-08-07 Impact factor: 4.634